BMY vs RVSB · P/E 17, rev $24.46B vs P/E 25, rev $15.3M
Bristol-Myers Squibb Company (BMY) versus Riverview Bancorp Inc (RVSB) — a side-by-side from cached financials, not a winner call.
Bristol-Myers Squibb Company (BMY) is a drug manufacturers - general company listed on US. It is led by Christopher S. Boerner Ph.D..
Riverview Bancorp Inc (RVSB) is a banks - regional company listed on US.
Latest reported BMY revenue for 2026-06-30 was $24.46B. Net income was $5.99B. BMY currently screens at market cap $95.36B and trailing P/E 17.5.
Latest reported RVSB revenue for 2026-03-31 was $15.3M. Net income was -$8.0M. Revenue was up 5.5% from 2025-03-31 to 2026-03-31. RVSB currently screens at market cap $120.6M and trailing P/E 25.0.
BMY currently screens at market cap $95.36B and trailing P/E 17.5. RVSB currently screens at market cap $120.6M and trailing P/E 25.0.
Not investment advice. Open the BMY and RVSB stock pages for the full models.
Not investment advice.